13F HOLDINGS REPORT
BIOS Capital Management, LP
Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0001104659-25-110482
Total Value
$88.9M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,594,141 | $57.5M | 64.66% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,455,855 | $9.7M | 10.95% |
| 3 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $7.4M | 8.35% |
| 4 | OPUS GENETICS INC | IRD | 3,683,429 | $6.6M | 7.42% |
| 5 | LANTERN PHARMA INC | LTRN | 1,015,715 | $4.4M | 4.97% |
| 6 | REIN THERAPEUTICS INC | RNTX | 1,498,751 | $1.7M | 1.94% |
| 7 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $675,128 | 0.76% |
| 8 | IN8BIO INC | INAB | 286,664 | $622,061 | 0.70% |
| 9 | REIN THERAPEUTICS INC | RNTX | 192,000 | $220,800 | 0.25% |